about
Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemRegulatory lymphocytes are key factors in MHC-independent resistance to EAEA cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.Chemical probes for the recognition of cannabinoid receptors in native systems.Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide.PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisCannabinoid system and neuroinflammation: implications for multiple sclerosis.The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB.2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination.Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress.Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: implications for remyelination at lesions sites.Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis.A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.Microglia activation states and cannabinoid system: Therapeutic implications.2-AG limits Theiler's virus induced acute neuroinflammation by modulating microglia and promoting MDSCs.Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation[Cannabinoid system and neuroinflammation:therapeutic perspectives in multiple sclerosis]Therapeutic potential of CB2 targeting in multiple sclerosis[Guidelines on the appropriate use of animal models for developing therapies in multiple sclerosis]Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosisA Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis
P50
Q26865295-391814FA-1511-433F-B6CF-86D19AE326A3Q33608305-EDDE70BF-C493-4442-A33A-86A8DCE1AA3AQ34299290-7FB29F4F-5037-4122-A639-61AE7295A766Q34639134-26541740-E92A-4D86-ABF3-55FBFD674177Q34801333-A65C222C-B7C7-4A9E-A3C1-D57577E4F27EQ36016406-C5B1FFDD-CEE9-4B97-BE35-A8110880DF09Q37029701-21068772-293B-45A4-97F9-D2062CF79FEBQ37568632-3F6AF06A-4645-4C97-8DE5-18BADF765F7BQ37698703-1AEC2558-D312-4702-883A-F77530C38C16Q38064230-2B19F6A2-3F90-4F16-A2D3-65010453BFD8Q39831195-37E214F7-CDC5-4EE5-A167-6607F53B7896Q40104988-61DD274F-C3D2-46D2-B58D-D4964C302A9BQ40440754-A0EE0C1D-17A5-4F59-8130-8C23DC670D0AQ42222868-9539009A-14E5-4057-A7C3-D1C94F034B62Q42260562-A9F135A0-D53C-492C-B820-9B6628163A4DQ42284004-EEF304AC-1B42-4D41-B1B1-C95809ACB565Q43265002-946034C3-96E6-473C-93CE-DE6DA5E25811Q44124410-BDD461F8-0A4C-4CBE-8AE1-B40A55D8C683Q45220912-2B7FC09D-4DD6-416C-8765-CC89B04FEBCAQ46768353-3229AB26-6554-4EFD-87DA-383B0BE9AC08Q46931542-D8F143AE-517A-44BB-A049-CB065EF96782Q48486771-F5152799-DE53-4063-924F-435EAE579932Q51666696-2C76D9AD-416F-4D29-B799-9FB88F3F5F83Q52372355-45E129F4-E136-4040-BC82-95FC3BC5CE10Q52678835-211CA8A9-A156-4739-8E54-F4BCE5C91304Q60597674-138B6890-4949-47C3-A95A-82E6783637D0Q60696495-A61A2F8A-6BCC-4E62-A9E5-CCCFCFB0EDE3Q80521829-BF375F66-62B5-4AF4-BD9E-2204884C0612Q83206428-9A7DEB82-5D79-4C7A-AB3A-BDD314754BD5Q91256665-D5549A7D-3327-4B31-A8F1-C45F2B8C5F01Q91781198-BDE28341-EE24-4BF3-92FA-98EE841C4D69
P50
description
researcher ORCID ID = 0000-0001-6970-2316
@en
wetenschapper
@nl
name
L Mestre
@ast
L Mestre
@en
L Mestre
@nl
type
label
L Mestre
@ast
L Mestre
@en
L Mestre
@nl
prefLabel
L Mestre
@ast
L Mestre
@en
L Mestre
@nl
P106
P31
P496
0000-0001-6970-2316